Chondrocyte container and method of use
Devices and methods for delivering a therapeutic agent produced via a genetically-altered chondrocyte are provided. More specifically, the device includes a housing which defines a cell chamber configured to retain a large volume of chondrocytes while selectively releasing therapeutic agents produced via these entrapped cells. In an exemplary embodiment, the cell chamber can be configured such that a portion of cells can be positioned at least about 1.5 mm from an external wall of the device (i.e., about 1.5 mm away from an external nutrient supply). For example, the cell chamber can have a tubular configuration having a length and a diameter wherein each of these dimensions is at least about 3 mm (thereby the central core to the chamber is at least about 1.5 mm from the outer wall of the device).
1. A method for delivering a therapeutic agent to a surgical site, comprising:
utilizing a delivery device comprising a cell chamber, an auxiliary fluid chamber, and an expandable chamber; the auxiliary fluid chamber being positioned between the cell chamber and the expandable chamber;
disposing a plurality of chondrocytes in the cell chamber, the cell chamber being configured to retain the chondrocytes, and further configured to allow for release of a therapeutic agent produced by the chondrocytes;
delivering the delivery device to a surgical site; and
delivering the therapeutic agent from the device to the surgical site.
2. The method of claim 1 , further comprising:
suturing the delivery device at the treatment site.
3. The method claim 1 further comprising:
injecting additional chondrocytes into the delivery device.
4. The method of claim 1 , wherein the auxiliary fluid chamber is configured to house an auxiliary fluid and the auxiliary fluid chamber is separated from the cell chamber via a semi-permeable membrane.
5. The method of claim 1 , wherein the auxiliary fluid chamber is configured to deliver an auxiliary fluid to the cell chamber.
6. The method of claim 5 , wherein the expandable chamber includes an osmotic membrane configured to allow for the input of fluid to the expandable chamber such that auxiliary fluid is controllably introduced to the cell chamber in response to the expansion of the expandable chamber.
7. The method of claim 1 , wherein the expandable chamber is separated from the auxiliary fluid chamber by a piston element.
8. The method of claim 7 , wherein the expandable chamber houses a water swellable agent configured to supply a force to the piston element in response to an input of water.
9. The method of claim 1 , wherein the auxiliary fluid includes cell nutrients.
10. The method of claim 1 , wherein the auxiliary fluid includes an agent capable of modifying an aspect of chondrocyte performance.